Liu, Hao <br/><br/>
B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.  [electronic resource] 

 -  Molecular cancer therapeutics  Jun 2011 
 - 960-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-11-0072  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD--biosynthesis<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Apoptosis--drug effects<br/>B7 Antigens<br/>Breast Neoplasms--genetics<br/>Cell Line<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Inhibitor of Apoptosis Proteins--genetics<br/>Janus Kinase 2--metabolism<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Myeloid Cell Leukemia Sequence 1 Protein<br/>Paclitaxel--pharmacology<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>RNA, Small Interfering--administration & dosage<br/>Receptors, Immunologic--biosynthesis<br/>STAT3 Transcription Factor--metabolism<br/>Survivin